Dentsply Sirona Inc (XRAY) SEC News Jan. 14, 2026, 12:55 UTC 0 1 comments (75% Positive) Dentsply Sirona Inc (XRAY) Files Form 8-K Comment Full text
Lexaria Bioscience Corp. (LEXX) SEC News Jan. 14, 2026, 12:52 UTC 6 0 comments New Form 25-NSE - Lexaria Bioscience Corp. Filed: 2026-01-14 AccNo: 0001354457-26-000039 Size: 3 KB Comment Full text
AngioDynamics Inc (ANGO) SEC News Jan. 14, 2026, 12:33 UTC 0 1 comments (85% Positive) AngioDynamics Inc (ANGO) Provides Update on management for future operations Comment Full text
Incannex Healthcare Ltd (IXHL) SEC News Jan. 14, 2026, 12:30 UTC 0 1 comments (90% Positive) Incannex Healthcare Ltd (IXHL) Provides Update on million for continued execution Comment Full text
C4 Therapeutics Inc (CCCC) SEC News Jan. 14, 2026, 12:12 UTC 0 1 comments (90% Positive) C4 Therapeutics Inc (CCCC) Announces Enrollment Update for Initiate Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Laboratory Corporation of America Holdings (LH) SEC News Jan. 14, 2026, 11:53 UTC 0 1 comments (99% Neutral) Laboratory Corporation of America Holdings (LH) Files Form 8-K Comment Full text
Nuvalent Inc (NUVL) SEC News Jan. 14, 2026, 11:30 UTC 0 1 comments (10% Negative) Nuvalent Inc (NUVL) Announces Delay in adult patients Trials for clinically proven kinase targets in cancer Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review Comment Full text
cbdMD Inc. (YCBD) SEC News Jan. 14, 2026, 11:06 UTC 9 0 comments New Form EFFECT - cbdMD, Inc. Filed: 2026-01-13 AccNo: 9999999995-26-000160 Size: 1 KB Comment Full text
Plus Therapeutics Inc (PSTV) SEC News Jan. 14, 2026, 11:06 UTC 7 0 comments New Form EFFECT - PLUS THERAPEUTICS, INC. Filed: 2026-01-13 AccNo: 9999999995-26-000164 Size: 1 KB Comment Full text
Briacell Therapeutics Corp (BCTX) SEC News Jan. 14, 2026, 11:06 UTC 8 0 comments New Form EFFECT - BriaCell Therapeutics Corp. Filed: 2026-01-13 AccNo: 9999999995-26-000157 Size: 1 KB Comment Full text